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This Month in the Journal
For this issue of The American Journal of Human Ge-
netics, Dr. Miron Baron has contributed a review article
on the genetics of schizophrenia (p. 299). In it, he sum-
marizes the genetic regions that have been implicated in
this disorder, and he also discusses the challenges as-
sociated with the identification of genetic loci that are
involved in a complex, psychiatric disorder.
Wild-Type Huntington Reduces Apoptosis, by Leavitt
et al. (p. 313)
Polyglutamine expansions, intracellular aggregates, and
neuronal cell death—these are all characteristic of
Huntington disease; but what is the pathological mech-
anism? Through use of transgenic mice expressing hu-
man huntingtin (htt), Leavitt et al. think they’ve found
a clue. The authors bred mice that express mutant hu-
man htt in the absence of endogenous mouse htt. These
mice are infertile, and this infertility is associated with
testicular degeneration and, in the spermatids and Sertoli
cells, abnormal intracellular protein aggregates and mis-
localized actin filaments. The authors believe that the
mutant phenotype is a downstream consequence of a
massive increase in apoptosis in the spermatogenic cells
of these mice. The phenotype can be rescued through
the expression of normal levels of wild-type mouse htt
in the transgenic mice, thereby contradicting the hy-
pothesis that mutant htt has a toxic gain of function.
The results instead suggest that the abnormalities seen
in mice expressing mutant htt are a consequence of the
loss of normal htt activity, which the authors believe is
antiapoptotic.
PRX Mutations Cause Recessive DSN, by Boerkoel et
al. (p. 325)
The recent finding that Prx knockout mice develop a
severe demyelinating neuropathy has led Jim Lupski and
his colleagues to hypothesize that the human orthologue
of Prx is mutated in some human inherited myelino-
pathies. Prx encodes periaxin, a protein that is thought
to be involved in stabilization of the myelin sheath of
axons. Human PRX maps to chromosome 19q13.3-
q13.2, within a genetic interval that has recently been
mapped for autosomal recessive myelinopathy. Genetic
sequence from 168 patients with peripheral neuropathy
revealed that 3 had mutations in PRX. These mutations
lead to the loss of the acidic domain in the carboxy
terminal portion of periaxin. Although the consequences
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of this loss are not yet known, the authors propose that
the domain may mediate a protein-protein interaction
that is essential for periaxin function and that mutations
in the other components of this interaction may also be
associated with neuropathies.
Genomic Divergences among Hominoids, by Chen
and Li (p. 444)
Estimates of the sequence divergence between human
and nonhuman primates have largely relied on DNA
hybridization data and sequence data from a limited
number of genetic regions. To make more-accurate es-
timates of this sequence divergence, Chen and Li have
obtained DNA sequence from several intergenic, non-
repetitive regions and have compared them between hu-
mans, chimpanzees, orangutans, and gorillas. Noncod-
ing regions are not subject to natural selection in the
same way that coding regions are, so they should provide
a more accurate and general picture of evolution. The
average sequence divergence between humans and chim-
panzees was found to be 1.24%  0.07%, a substan-
tially lower estimate than had previously been calcu-
lated, possibly because repetitive sequences have been
excluded from Chin and Li’s calculations. The data were
also used to estimate the effective population size of the
common ancestor of humans and chimpanzees, which
was approximately five to nine times larger than the
estimate of the long-term effective population size for
humans. These results indicate that there has been a
significant reduction in the effective population size in
the human lineage since we diverged from chimpanzees.
Brain mtDNA D-Loop Variants, by Chinnery et al.
(p. 529)
Last year, Science published a report, by Michikawa et
al. (see the References list in Chinnery et al.), suggesting
that point mutations in the mtDNA control region ap-
pear with normal advancing age. These data are intrigu-
ing because it has been postulated that accumulation of
mtDNAmutations might play a role in the aging process.
Concerned with the role of mtDNA mutations in the
aging of the brain, Chinnery et al. have examined this
phenomenon in brain tissue. In neither normal, aged
brains nor brains from patients with neurodegenerative
disease did they detect any of the mtDNA control-region
mutations that were observed by Michikawa et al. in
cultured skin fibroblasts. Perhaps this is due to the fact
that Chinnery et al. used primary tissue in their exper-
iments. They suggest that, in culture, selection for the
Am. J. Hum. Genet. 68:i–ii, 2001
ii
variant mtDNA molecules may lead to the appearance
of mutations, as reported by Michikawa et al. Whatever
the reason for the discrepancy, it appears that, on the
issue of mtDNA mutations and aging, the jury is still
out.
Inheritance of mtDNA Heteroplasmy, by Brown et al.
(p. 533)
It is pretty much impossible to predict the likelihood
that a woman who carries a heteroplasmicmtDNApoint
mutation will bear a severely affected child, because of
the fact that these women transmit variable amounts of
mutant DNA to their offspring. Since we do not yet
understand the mechanism of transmission of hetero-
plasmic mtDNA to the offspring, we cannot estimate
what proportion of mutant mtDNA a child will carry.
To better understand heteroplasmic mtDNA transmis-
sion, previous studies included comparisons, between
mothers and their children, of the mutant load, as mea-
sured in blood samples. Although these studies provide
useful information, the results could be complicated by
ascertainment bias, since families are identified through
affected individuals, and by the fact that mutant load
can change with age (see Chinnery et al. 2000c in the
References list of Brown et al.). To look at mtDNA trans-
mission more directly, Brown et al. measured the mutant
load in primary oocytes from a woman who carries the
A3243G mtDNA mutation. The frequency distribution
of mutant load in the oocytes is binomial and centered
around the mean. Because this distribution is not
skewed, Brown et al. conclude that selection for or
against the mutant mtDNA sequences is not occurring
but, rather, that the level of mutant mtDNA in the
oocytes is determined by random genetic drift. Thiswork
provides the first look at mtDNA transmission in the
absence of ascertainment bias, and it puts us on the road
to being able to provide accurate genetic counseling for
women with heteroplasmic mtDNA mutations.
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